Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease-Reference-Cited by-同舟云学术

Trial of Solanezumab for Mild Dementia Due to Alzheimer’s Disease

Published:2018-01-25 Issue:4 Volume:378 Page:321-330
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Honig Lawrence S.¹,Vellas Bruno¹,Woodward Michael¹,Boada Mercè¹,Bullock Roger¹,Borrie Michael¹,Hager Klaus¹,Andreasen Niels¹,Scarpini Elio¹,Liu-Seifert Hong¹,Case Michael¹,Dean Robert A.¹,Hake Ann¹,Sundell Karen¹,Poole Hoffmann Vicki¹,Carlson Christopher¹,Khanna Rashna¹,Mintun Mark¹,DeMattos Ronald¹,Selzler Katherine J.¹,Siemers Eric¹

Affiliation:

1. From the Department of Neurology and Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University Medical Center, New York (L.S.H.); Gérontopôle, Centre Hospitalier Universitaire Toulouse, Unité Mixte de Recherche INSERM Unité 1027 Université Toulouse III–Paul Sabatier, Toulouse, France (B.V.); Austin Health Continuing Care Clinical Service Unit, Heidelberg, and the University of Melbourne, Melbourne, VIC — both in Australia (M.W.); Fundació ACE, Alzheimer Research Center...

Funder

Eli Lilly and Company

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1705971

Cited by 758 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The amyloid-β peptide: Guilty as charged?;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

2. Passive immunotherapy for Alzheimer's disease;Ageing Research Reviews;2024-02

3. Alzheimer’s Dementia or Alzheimer’s Disease;Dispatches from the Land of Alzheimer's;2024-01-31

4. Mitophagy in Alzheimer’s Disease: A Bibliometric Analysis from 2007 to 2022;Journal of Alzheimer's Disease Reports;2024-01-29

5. Lessons Learned from Approval of Aducanumab for Alzheimer's Disease;Annual Review of Medicine;2024-01-29